Skip to main content
. 2014 Apr 21;4(1):37–50. doi: 10.1016/j.jceh.2014.02.005

Table 6.

Therapeutic Goals for Children (Modified from Pastores et al74).

Anemia
  • Increase Hb levels within 1–2 years to >11.0 g/dl and maintain Hb

  • Eliminate blood transfusion dependency

  • Reduce fatigue and dyspnea

Thrombocytopenia
  • Increase platelet counts during the 1st year of treatment >60 × 103 cells/mm3

  • Moderate thrombocytopenia: Count should increase by 1.5- to 2.0-fold by 1 year and low-normal level by 2 years

  • Severe thrombocytopenia: Counts should increase by 1.5- fold by 1 year and double by 2 years but normalization is not expected

  • Avoid splenectomy

Hepatomegaly
  • Reduce and maintain the liver volume to <1.5 fold.

  • Reduce the liver volume by 20–30% within 1–2 years and by 30–40% by 5 years

Splenomegaly
  • Reduce and maintain spleen volume to <2–8-fold normal

  • Reduce the spleen volume by 30% within 1 year and 60% by 2–5 years

  • Alleviate symptoms due to splenomegaly

Bones
  • Lessen or eliminate bone pain within 2 years of treatment

  • Prevent bone crises

  • Prevent osteonecrosis and joint collapse

  • Improve bone mineral density by 2 years of treatment

  • Attain normal or ideal peak skeletal mass

Growth
  • Achieve normal height within 3 years of treatment

  • Achieve normal onset of puberty